Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Mar 27 2026

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE · · 2 pages · English

Release

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 27, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Paroxetine Extended-Release Tablets USP, 12.5 mg.".

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases